Pharma giant GSK quits Stevenage for Cambridge

GSK is closing its R&D hub in Stevenage to open a new site in Cambridge. This strategic relocation aims to place 1,000 R&D staff within the heart of the UK's life sciences Golden Triangle. The transition will impact approximately 1,800 employees currently based at the Stevenage facility. The pharma giant is shifting its operations to enhance its research capabilities by integrating more closely with the specialised scientific community located in the Cambridge region.